• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Pragmatic Free Trial Meta

Pragmatic Free Trail Meta is an open data platform that facilitates research into pragmatic trials. It collects and distributes clean trial data, ratings and evaluations using PRECIS-2. This permits a variety of meta-epidemiological analyses that compare treatment effect estimates across trials of different levels of pragmatism.

Background

Pragmatic trials are increasingly acknowledged as providing evidence from the real world for clinical decision-making. However, the usage of the term "pragmatic" is not uniform and its definition and assessment requires further clarification. The purpose of pragmatic trials is to inform clinical practices and policy choices, rather than confirm a physiological hypothesis or clinical hypothesis. A pragmatic study should strive to be as close as possible to real-world clinical practices which include the recruiting participants, setting, designing, implementation and delivery of interventions, determining and analysis results, as well as primary analyses. This is a major difference from explanatory trials (as described by Schwartz and Lellouch1) that are designed to provide more complete confirmation of an idea.

The most pragmatic trials should not conceal participants or clinicians. This could lead to bias in the estimations of the effect of treatment. Practical trials should also aim to enroll patients from a variety of health care settings so that their results can be compared to the real world.

Finally, pragmatic trials must be focused on outcomes that matter to patients, like the quality of life and functional recovery. This is particularly important in trials that involve invasive procedures or those with potential serious adverse events. The CRASH trial29 compared a 2-page report with an electronic monitoring system for hospitalized patients suffering from chronic cardiac failure. The catheter trial28, however was based on symptomatic catheter-related urinary tract infection as its primary outcome.

In addition to these characteristics pragmatic trials should also reduce trial procedures and data-collection requirements to cut costs and time commitments. In the end the aim of pragmatic trials is to make their findings as relevant to real-world clinical practices as possible. This can be accomplished by ensuring that their analysis is based on the intention to treat approach (as described within CONSORT extensions).

Despite these requirements, many RCTs with features that defy the notion of pragmatism were incorrectly labeled pragmatic and published in journals of all types. This could lead to false claims of pragmatism and the term's use should be standardized. The development of the PRECIS-2 tool, which provides an objective standard for 프라그마틱 환수율 assessing practical features, is a good first step.

Methods

In a pragmatic research study, the goal is to inform policy or clinical decisions by showing how an intervention could be integrated into routine treatment in real-world situations. Explanatory trials test hypotheses concerning the cause-effect relationship within idealised settings. In this way, pragmatic trials can have lower internal validity than explanatory studies and are more susceptible to biases in their design, analysis, and conduct. Despite these limitations, pragmatic trials can provide valuable information to decision-making in the context of healthcare.

The PRECIS-2 tool evaluates an RCT on 9 domains, ranging between 1 and 5 (very pragmatic). In this study, the recruit-ment, organisation, flexibility: delivery, flexible adherence and follow-up domains scored high scores, however the primary outcome and the procedure for missing data were not at the practical limit. This suggests that a trial can be designed with effective pragmatic features, without damaging the quality.

However, it is difficult to judge the degree of pragmatism a trial is since pragmaticity is not a definite attribute; some aspects of a trial may be more pragmatic than others. The pragmatism of a trial can be affected by changes to the protocol or logistics during the trial. In addition 36% of 89 pragmatic trials identified by Koppenaal et al were placebo-controlled or conducted before licensing, and the majority were single-center. This means that they are not as common and are only pragmatic in the event that their sponsors are supportive of the absence of blinding in these trials.

A common feature of pragmatic studies is that researchers try to make their findings more meaningful by studying subgroups within the trial sample. This can result in imbalanced analyses and lower statistical power. This increases the possibility of missing or misdetecting differences in the primary outcomes. In the case of the pragmatic studies included in this meta-analysis, this was a major issue because the secondary outcomes weren't adjusted for the differences in the baseline covariates.

Furthermore the pragmatic trials may present challenges in the gathering and interpretation of safety data. This is due to the fact that adverse events are typically self-reported, and therefore are prone to errors, delays or coding variations. Therefore, it is crucial to improve the quality of outcomes for these trials, ideally by using national registry databases instead of relying on participants to report adverse events on the trial's own database.

Results

Although the definition of pragmatism does not require that all trials be 100 100% pragmatic, there are advantages to incorporating pragmatic components into clinical trials. These include:

Increased sensitivity to real-world issues which reduces cost and size of the study as well as allowing trial results to be more quickly transferred into real-world clinical practice (by including patients who are routinely treated). However, pragmatic trials may be a challenge. The right type of heterogeneity, for example could allow a study to expand its findings to different patients or settings. However, the wrong type can decrease the sensitivity of the test, and therefore reduce a trial's power to detect even minor effects of treatment.

A number of studies have attempted to categorize pragmatic trials, using various definitions and scoring systems. Schwartz and Lellouch1 developed a framework to differentiate between explanation studies that confirm the physiological hypothesis or clinical hypothesis, and pragmatic studies that inform the selection of appropriate therapies in real world clinical practice. The framework was composed of nine domains assessed on a scale of 1-5 with 1 being more explanatory while 5 was more practical. The domains covered recruitment and setting up, the delivery of intervention, flexible adhering to the program and 프라그마틱 무료 슬롯 primary analysis.

The original PRECIS tool3 featured similar domains and an assessment scale ranging from 1 to 5. Koppenaal et al10 devised an adaptation to this assessment dubbed the Pragmascope that was simpler to use in systematic reviews. They found that pragmatic reviews scored higher in most domains, but scored lower in the primary analysis domain.

This distinction in the main analysis domain could be due to the fact that the majority of pragmatic trials analyse their data in an intention to treat manner however some explanation trials do not. The overall score for systematic reviews that were pragmatic was lower when the domains of management, flexible delivery and follow-up were merged.

It is crucial to keep in mind that a pragmatic study does not necessarily mean a low-quality study. In fact, there is increasing numbers of clinical trials which use the term "pragmatic" either in their title or 프라그마틱 정품 abstract (as defined by MEDLINE, but that is neither sensitive nor precise). The use of these terms in titles and abstracts could indicate a greater understanding of the importance of pragmatism, but it isn't clear if this is reflected in the content of the articles.

Conclusions

In recent years, pragmatic trials have been gaining popularity in research as the value of real world evidence is becoming increasingly acknowledged. They are clinical trials that are randomized that compare real-world care alternatives instead of experimental treatments in development, they include populations of patients which are more closely resembling the ones who are treated in routine care, they use comparisons that are commonplace in practice (e.g., existing medications), 슬롯 and they depend on participants' self-reports of outcomes. This method is able to overcome the limitations of observational research, like the biases associated with the reliance on volunteers and the limited availability and the coding differences in national registry.

Pragmatic trials also have advantages, 프라그마틱 정품 like the ability to leverage existing data sources, and a greater probability of detecting meaningful differences from traditional trials. However, these tests could still have limitations which undermine their validity and generalizability. Participation rates in some trials may be lower than anticipated due to the healthy-volunteering effect, financial incentives, or competition from other research studies. Practical trials are often restricted by the necessity to recruit participants quickly. In addition, some pragmatic trials don't have controls to ensure that the observed differences aren't due to biases in the conduct of trials.

The authors of the Pragmatic Free Trial Meta identified RCTs published from 2022 to 2022 that self-described themselves as pragmatic. The PRECIS-2 tool was employed to assess the pragmatism of these trials. It includes domains such as eligibility criteria as well as recruitment flexibility and adherence to intervention and follow-up. They found that 14 of these trials scored pragmatic or highly sensible (i.e. scoring 5 or more) in any one or more of these domains and that the majority of them were single-center.

Studies with high pragmatism scores are likely to have more lenient criteria for eligibility than traditional RCTs. They also include populations from many different hospitals. The authors suggest that these traits can make pragmatic trials more effective and relevant to everyday practice, but they don't necessarily mean that a trial conducted in a pragmatic manner is free of bias. The pragmatism characteristic is not a definite characteristic and a test that does not have all the characteristics of an explanatory study may still yield valid and useful outcomes.